Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer

H Yasuda - Nitric Oxide, 2008 - Elsevier
Hypoxia exists in solid tumor tissues due to abnormal vasculature, vascular insufficiency,
treatment or malignancy related anemia, and low intratumor blood flow. Hypoxic status in …
被引用次数：258 相关文章

Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.

H Yasuda - Nitric Oxide: Biology and Chemistry, 2008 - europepmc.org
Hypoxia exists in solid tumor tissues due to abnormal vasculature, vascular insufficiency,
treatment or malignancy related anemia, and low intratumor blood flow. Hypoxic status in …

Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer

H Yasuda - Nitric oxide: biology and chemistry, 2008 - pubmed.ncbi.nlm.nih.gov
Hypoxia exists in solid tumor tissues due to abnormal vasculature, vascular insufficiency,
treatment or malignancy related anemia, and low intratumor blood flow. Hypoxic status in …

[引用][C] Solid tumor physiology and hypoxia-induced chemo/radio-resistance: Novel strategy for cancer therapy: Nitric oxide donor as a therapeutic enhancer

H Yasuda - Nitric Oxide, 2008 - cir.nii.ac.jp
Solid tumor physiology and hypoxia-induced chemo/radio-resistance: Novel strategy for cancer
therapy: Nitric oxide donor as a therapeutic enhancer | CiNii Research CiNii 国立情報学研究所 …

Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer

H Yasuda - Nitric Oxide, 2008 - hero.epa.gov
Hypoxia exists in solid tumor tissues due to abnormal vasculature, vascular insufficiency,
treatment or malignancy related anemia, and low intratumor blood flow. Hypoxic status in …

Solid tumor physiology and hypoxia-induced chemo/radio-resistance: Novel strategy for cancer therapy: Nitric oxide donor as a therapeutic enhancer

H Yasuda - Nitric Oxide, 2008 - infona.pl
Hypoxia exists in solid tumor tissues due to abnormal vasculature, vascular insufficiency,
treatment or malignancy related anemia, and low intratumor blood flow. Hypoxic status in …

Solid tumor physiology and hypoxia-induced chemo/radio-resistance: Novel strategy for cancer therapy: Nitric oxide donor as a therapeutic enhancer

H Yasuda - Nitric Oxide, 2008 - infona.pl
Hypoxia exists in solid tumor tissues due to abnormal vasculature, vascular insufficiency,
treatment or malignancy related anemia, and low intratumor blood flow. Hypoxic status in …

[引用][C] Solid tumor physiology and hypoxia-induced chemo/radio-resistance: Novel strategy for cancer therapy: Nitric oxide donor as a therapeutic enhancer

H YASUDA - Nitric oxide, 2008 - Elsevier